Rubert A, Bagán
L, Bagán JV. Oral leukoplakia, a clinical-histopathological study in 412
patients. J Clin Exp Dent. 2020;12(6):e540-6.
doi:10.4317/jced.57091
https://doi.org/10.4317/jced.57091
______________________________________________
References
|
1.
van der Waal I. Oral potentially malignant disorders: is malignant
transformation predictable and preventable?. Med Oral Patol Oral Cir Bucal.
2014;19:e386-90. |
|
|
|
|
|
2.
Brouns ER, Baart JA, Bloemena E, Karagozoglu H, van der Waal I. The relevance
of uniform reporting in oral leukoplakia: definition, certainty factor and
staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal.
2013;18:e19-26. |
|
|
|
|
|
3.
van der Waal I. Oral leukoplakia, the ongoing discussion on definition and
terminology. Med Oral Patol Oral Cir Bucal. 2015;20:e685-92. |
|
|
|
|
|
4.
Petti S. Pooled estimate of world leukoplakia prevalence: a systematic
review. Oral Oncol. 2003;39:770-80. |
|
|
|
|
|
5.
Napier SS, Speight PM. Natural history of potentially malignant oral lesions
and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1-10. |
|
|
|
|
|
6.
García-Pola Vallejo MJ, García Martín JM. Oral leukoplakia. Aten Primaria.
2002;29:39-49. |
|
|
|
|
|
7.
van der Waal I. Potentially malignant disorders of the oral and oropharyngeal
mucosa; present concepts of management. Oral Oncol. 2010;46:423-5. |
|
|
|
|
|
8.
Kumar A, Cascarini L, McCaul JA, Kerawala CJ, Coombes D, Godden D, Brennan
PA. How should we manage oral leukoplakia? Br J Oral Maxillofac Surg. 2013;51:377-83. |
|
|
|
|
|
9.
Lodi G, Porter S. Management of potentially malignant disorders: evidence and
critique. J Oral Pathol Med. 2008;37:63-9. |
|
|
|
|
|
10.
van der Waal I. Potentially malignant disorders of the oral and oropharyngeal
mucosa; terminology, classification and present concepts of management. Oral
Oncol. 2009;45:317-23. |
|
|
|
|
|
11.
Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and
classification of potentially malignant disorders of the oral mucosa. J Oral
Pathol Med. 2007;36:575-80. |
|
|
|
|
|
12.
Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant
transformation. A follow-up study of 257 patients. Cancer.1984;53:563-8. |
|
|
|
|
|
13.
Schepman KP, Bezemer PD, van der Meij EH, Smeele LE, van der Waal I. Tobacco
usage in relation to the anatomical site of oral leukoplakia. Oral Dis.
2001;7:25-7. |
|
|
|
|
|
14.
Napier SS, Cowan CG, Gregg TA, Stevenson M, Lamey PJ, Toner PG. Potentially
malignant oral lesions in Northern Ireland: size (extent) matters. Oral Dis.
2003;9:129-37. |
|
|
|
|
|
15.
Maserejian NN, Giovannucci E, Rosner B, Zavras A, Joshipura K. Prospective
study of fruits and vegetables and risk of oral premalignant lesions in men.
Am J Epidemiol. 2006;164:556-66. |
|
|
|
|
|
16.
Vladimirov BS, Schiodt M. The effect of quitting smoking on the risk of
unfavorable events after surgical treatment of oral potentially malignant
lesions. Int J Oral Maxillofac Surg. 2009;38:1188-93. |
|
|
|
|
|
17.
Haya-Fernández MC, Bagán JV, Murillo-Cortés J, Poveda-Roda R, Calabuig C. The
prevalence of oral leukoplakia in 138 patients with oral squamous cell carcinoma.
Oral Dis. 2004;10:346-8. |
|
|
|
|
|
18.
Scheifele C, Reichart PA, Dietrich T. Low prevalence of oral leukoplakia in a
representative sample of the US population. Oral Oncol. 2003;39:619-25. |
|
|
|
|
|
19.
Vázquez-Álvarez R, Fernández-González F, Gándara-Vila P, Reboiras- López D,
García-García A, Gándara-Rey JM. Correlation between clini- cal and
pathologic diagnosis in oral leukoplakia in 54 patients. Med Oral Patol Oral
Cir Bucal. 2010;15:e832-8. |
|
|
|
|
|
20.
Starzyńska A, Pawłowska A, Renkielska D, Michajłowski I, Sobjanek M,
Błażewicz I. Oral premalignant lesions: epidemiological and clinical analysis
in the northern Polish population. Postȩpy Dermatol Alergol. 2014;31:341-350. |
|
|
|
|
|
21.
Holmstrup P, Vedtofte P, Reibel J, Stoltze K. Long-term treatment outcome of
oral premalignant lesions. Oral Oncol. 2006;42:461-74. |
|
|
|
|
|
22.
Brouns E, Baart J, Karagozoglu Kh, Aartman I, Bloemena E, van der Waal I.
Malignant transformation of oral leukoplakia in a well-defined cohort of 144
patients. Oral Dis. 2014;20:e19-24. |
|
|
|
|
|
23.
Neville BW, Day TA. Oral cancer and precancerous lesions. CA Cancer J Clin.
2002;52:195-215. |
|
|
|
|
|
24.
Gandara-Vila P, Perez-Sayans M, Suarez-Penaranda JM, Gallas-Torreira M,
Somoza-Martin J, Reboiras-Lopez MD, et al. Survival study of leukoplakia
malignant transformation in a region of northern Spain. Med Oral Patol Oral
Cir Bucal. 2018;23:e413-e420. |
|
|
|
|
|
25.
Einhorn J, Wersall J. Incidence of oral carcinoma in patients with
leukoplakia of the oral mucosa. Cancer. 1967;20:2189-93. |
|
|
|
|
|
26.
Pindborg JJ, Renstrup G, Jolst O, Roed-Peterson B. Studies in oral
leukoplakia: A preliminary report on the period prevalence of malignant
transformation in leukoplakia based in a follow-up study of 248 patients. J
Am Dent Assoc 1968;76:767-71. |
|
|
|
|
|
27.
Roed-Petersen B. Cancer development in oral leukoplakia follow-up of 331
patients. J Dent Res. 1971;50:711-2. |
|
|
|
|
|
28.
Banoczy J. Follow-up studies in oral leukoplakia. J Max Fac Surg. 1977;5:69-75. |
|
|
|
|
|
29.
Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, et
al. Factors predicting malignant transformation in oral potentially malignant
disorders among patients accrued over a 10-year period in South East England.
J Oral Pathol Med. 2011;40:677-83 |
|
|
|
|
|
30.
Reibel J. Prognosis of oral pre-malignant lesions: significance of clinical,
histopathological, and molecular biological characteristics. Crit Rev Oral
Biol Med. 2003;14:47-62. |
|